Reduced expression of NLRP3 and MEFV in human ischemic heart tissue

Biochemical and Biophysical Research Communications

Volumn 430, Issue 1, 2013, Pages 425-428

  Hermansson, Cecilia ^a   Lundqvist, Annika ^a   Wasslavik, Carina ^b   Palmqvist, Lars ^b   Jeppsson, Anders ^c   Hultén, Lillemor Mattsson ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiac tissue; Human; Inflammation; Ischemia

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; MEDITERRANEAN FEVER PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARDITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FAMILIAL MEDITERRANEAN FEVER; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HEART MUSCLE; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

CARRIER PROTEINS; CYTOSKELETAL PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMASOMES; MUTATION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RNA, MESSENGER;

EID: 84872424175     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.070     Document Type: Article

References (20)

1. Dong J.W., Vallejo J.G., Tzeng H.P., Thomas J.A., Mann D.L. Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H1079-H1087.
2. Ridker P.M., Thuren T., Zalewski A., Libby P. Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study. Am. Heart J. 2011, 162:597-605.
3. Magnusson L.U., Lundqvist A., Asp J., Synnergren J., Johansson C.T., Palmqvist L., Jeppsson A., Hulten L.M. High expression of arachidonate 15-lipoxygenase and proinflammatory markers in human ischemic heart tissue. Biochem. Biophys. Res. Commun. 2012, 424:327-330.
4. Galea J., Armstrong J., Gadsdon P., Holden H., Francis S.E., Holt C.M. Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb. Vasc. Biol. 1996, 16:1000-1006.
5. Hartford M., Wiklund O., Hulten L.M., Persson A., Karlsson T., Herlitz J., Hulthe J., Caidahl K. Interleukin-18 as a predictor of future events in patients with acute coronary syndromes. Arterioscler Thromb. Vasc. Biol. 2010, 30:2039-2046.
6. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.
7. Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature 2012, 481:278-286.
8. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nunez G., Schnurr M., Espevik T., Lien E., Fitzgerald K.A., Rock K.L., Moore K.J., Wright S.D., Hornung V., Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
9. Kawaguchi M., Takahashi M., Hata T., Kashima Y., Usui F., Morimoto H., Izawa A., Takahashi Y., Masumoto J., Koyama J., Hongo M., Noda T., Nakayama J., Sagara J., Taniguchi S., Ikeda U. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 2011, 123:594-604.
10. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., Hornung V., Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 2009, 183:787-791.
11. Verma D., Lerm M., Blomgran Julinder R., Eriksson P., Soderkvist P., Sarndahl E. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases?,. Arthritis Rheum. 2008, 58:888-894.
12. Verma D., Sarndahl E., Andersson H., Eriksson P., Fredrikson M., Jonsson J.I., Lerm M., Soderkvist P. The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1beta and IL-18 production. PLoS ONE 2012, 7:e34977.
13. Hoffman H.M., Mueller J.L., Broide D.H., Wanderer A.A., Kolodner R.D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 2001, 29:301-305.
14. Blomgran R., Patcha Brodin V., Verma D., Bergstrom I., Soderkvist P., Sjowall C., Eriksson P., Lerm M., Stendahl O., Sarndahl E. Common genetic variations in the NALP3 inflammasome are associated with delayed apoptosis of human neutrophils. PLoS ONE 2012, 7:e31326.
15. Grandemange S., Aksentijevich I., Jeru I., Gul A., Touitou I. The regulation of MEFV expression and its role in health and familial Mediterranean fever. Genes Immun. 2011, 12:497-503.
16. Harton J.A., Linhoff M.W., Zhang J., Ting J.P. Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J. Immunol. 2002, 169:4088-4093.
17. Ustek D., Ekmekci C.G., Selcukbiricik F., Cakiris A., Oku B., Vural B., Yanar H., Taviloglu K., Ozbek U., Gul A. Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. Arthritis Rheum. 2007, 56:345-350.
18. Notarnicola C., Didelot M.N., Kone-Paut I., Seguret F., Demaille J., Touitou I. Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever. Arthritis Rheum. 2002, 46:2785-2793.
19. Wu K., Xu W., You Q., Guo R., Feng J., Zhang C., Wu W. Increased expression of heat shock protein 90 under chemical hypoxic conditions protects cardiomyocytes against injury induced by serum and glucose deprivation. Int. J. Mol. Med. 2012.
20. Kanneganti T.D., Lamkanfi M., Kim Y.G., Chen G., Park J.H., Franchi L., Vandenabeele P., Nunez G. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007, 26:433-443.